Absolute risk regression for competing risks: interpretation, link functions, and prediction

In survival analysis with competing risks, the transformation model allows different functions between the outcome and explanatory variables. However, the model's prediction accuracy and the interpretation of parameters may be sensitive to the choice of link function. We review the practical implications of different link functions for regression of the absolute risk (or cumulative incidence) of an event. Specifically, we consider models in which the regression coefficients β have the following interpretation: The probability of dying from cause D during the next t years changes with a factor exp(β) for a one unit change of the corresponding predictor variable, given fixed values for the other predictor variables. The models have a direct interpretation for the predictive ability of the risk factors. We propose some tools to justify the models in comparison with traditional approaches that combine a series of cause-specific Cox regression models or use the Fine-Gray model. We illustrate the methods with the use of bone marrow transplant data.

[1]  J. Fine,et al.  Regression modeling of competing crude failure probabilities. , 2001, Biostatistics.

[2]  M. Schumacher,et al.  Consistent Estimation of the Expected Brier Score in General Survival Models with Right‐Censored Event Times , 2006, Biometrical journal. Biometrische Zeitschrift.

[3]  Thomas A Gerds,et al.  Efron‐Type Measures of Prediction Error for Survival Analysis , 2007, Biometrics.

[4]  David W. Hosmer,et al.  Applied Logistic Regression , 1991 .

[5]  E L Korn,et al.  Applications of crude incidence curves. , 1992, Statistics in medicine.

[6]  Mei-Jie Zhang,et al.  Flexible competing risks regression modeling and goodness-of-fit , 2008, Lifetime data analysis.

[7]  Mei-Jie Zhang,et al.  Analyzing Competing Risk Data Using the R timereg Package. , 2011, Journal of statistical software.

[8]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[9]  Jason P. Fine,et al.  Analysing competing risks data with transformation models , 1999 .

[10]  Zhiliang Ying,et al.  On the linear transformation model for censored data , 1998 .

[11]  Maja Pohar Perme,et al.  Pseudo-observations in survival analysis , 2010, Statistical methods in medical research.

[12]  Michael R. Kosorok,et al.  Temporal process regression , 2004 .

[13]  Harald Binder,et al.  Quantifying the predictive accuracy of time‐to‐event models in the presence of competing risks , 2011, Biometrical journal. Biometrische Zeitschrift.

[14]  H. Putter,et al.  Competing risks in epidemiology: possibilities and pitfalls. , 2012, International journal of epidemiology.

[15]  Per Kragh Andersen,et al.  Regression Analysis for Multistate Models Based on a Pseudo‐value Approach, with Applications to Bone Marrow Transplantation Studies , 2007 .

[16]  Susanne Rosthøj,et al.  Competing risks as a multi-state model , 2002, Statistical methods in medical research.

[17]  J Benichou,et al.  Estimates of absolute cause-specific risk in cohort studies. , 1990, Biometrics.

[18]  Mei-Jie Zhang,et al.  Summarizing differences in cumulative incidence functions , 2008, Statistics in medicine.

[19]  Mei-Jie Zhang,et al.  Predicting cumulative incidence probability by direct binomial regression , 2008 .

[20]  Harald Binder,et al.  Boosting for high-dimensional time-to-event data with competing risks , 2009, Bioinform..

[21]  I. C. Marschner,et al.  Relative risk regression: reliable and flexible methods for log-binomial models. , 2012, Biostatistics.

[22]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[23]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[24]  John P Klein,et al.  Regression Modeling of Competing Risks Data Based on Pseudovalues of the Cumulative Incidence Function , 2005, Biometrics.

[25]  J P Klein,et al.  Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Niels Keiding,et al.  Interpretability and importance of functionals in competing risks and multistate models , 2012, Statistics in medicine.

[27]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .